Evotec Stock – Fundamental Analysis
Fundamental Data & Ratios (Balance sheet update: 4/28/2026)
| Balance Sheet | Total Assets | 1,778,754,000.00 | ROE | 45.75 % |
| Balance Sheet | Total Equity | 813,704,000.00 | ROA | -5.82 % |
| Cashflow | Capital Expenditures | -72,542,000.00 | P/FCF | -5.65 |
| Cashflow | Free Cash Flow | -81,979,000.00 | – | – |
| Cashflow | Operating Cash Flow | -9,437,000.00 | P/CF | -49.12 |
| Income | Earnings per Share (diluted) | -0.58 | Div. Yield | – |
| Income | Net Income | -103,517,000.00 | P/E | -4.50 |
| Income | Shares Outstanding | 177,740,300.00 | P/B | 0.57 |
| Income | Total Revenue | 788,400,000.00 | P/S | 0.59 |
Ratios calculated on: 10/14/2026
Company Description
Evotec AG is a Germany-based parent company of the Evotec group, which is engaged in drug discovery and development company focused on providing integrated drug discovery services and alliances to the pharmaceutical and biotechnology industry. In addition, the Company has a small number of its own drug candidates at various stages of development either partnered or available for partnering. It provides integrated solutions to the pharmaceutical and biotechnology industry from target to clinical development through a range of capabilities and capacities, including early-stage assay development and screening, fragment-based drug discovery through to medicinal chemistry and in vivo and in vitro pharmacology. As of December 31, 2011, its primary operating entities included the United Kingdom-based Evotec (UK) Ltd, India-based Evotec (India) Private Ltd, the United States-based Compound Focus, Inc, and two Germany-based subsidiaries Kinaxo Biotechnologies GmbH and DeveloGen AG
Additional comparison and history views are available after login.
Finanzoo GmbH assumes no liability for the accuracy of the information provided! All information is provided without guarantee. Sources: www.bundesanzeiger.de, www.sec.gov, www.evotec.com
All metrics and scores are an automated evaluation and not investment advice or a recommendation to buy or sell. Finanzoo GmbH or its shareholders may themselves hold positions in the securities shown.
Learn more